Copyright: ©Author(s) 2026.
World J Gastroenterol. Sep 21, 2026; 32(35): 118677
Published online Sep 21, 2026. doi: 10.3748/wjg.118677
Published online Sep 21, 2026. doi: 10.3748/wjg.118677
Table 1 Basal characteristics of 101 participants with inflammatory bowel disease, n (%)/median (interquartile ranges)
| Variable | |
| Female | 60 (59.4) |
| Age in years | 49 (35-59) |
| Residency | |
| Mexico City | 45 (44.6) |
| State of Mexico | 17 (16.8) |
| State of Hidalgo | 10 (9.9) |
| Education level | |
| Illiterate | 1 (1.0) |
| Basic1 | 31 (30.7) |
| Intermediate2 | 22 (21.8) |
| Higher3 | 47 (46.5) |
| Smoking index | 0 (0-0.75) |
| Previous CDI | 9/98 (9.2) |
| Previous hospitalization4 | 9 (8.9) |
| Previous healthcare utilization4 | 23 (22.8) |
| Previous antibiotic use4 | 34/99 (34.3) |
| Previous statin use4 | 12 (11.9) |
| Proton pump inhibitor use4 | 39 (38.6) |
| Previous bowel surgery | 31 (30.7) |
| Age at diagnosis of IBD in years | 35 (26-50) |
| Disease duration at inclusion in years | 9 (4-16) |
| Type of IBD | |
| Ulcerative colitis | 78 (77.2) |
| Crohn’s disease | 22 (21.8) |
| Indeterminate colitis | 1 (1.0) |
| Extent of ulcerative colitis, n = 78 | |
| Proctitis | 11 (10.9) |
| Left-sided colitis | 19 (18.8) |
| Pancolitis | 48 (47.5) |
| Days without IBD activity before follow-up | 936 (238-1088) |
| Severity of last flare-up | |
| Mild | 23/60 (38.3) |
| Moderate | 32/60 (53.3) |
| Severe (uncomplicated) | 5/60 (8.4) |
| Treatment at baseline (not mutually exclusive) | |
| Sulfasalazine or mesalamine | 73/99 (73.7) |
| Corticosteroids | 34/99 (34.3) |
| Azathioprine | 32/99 (32.3) |
| Infliximab | 3/99 (3.0) |
| Methotrexate | 2/99 (2.0) |
| Laboratory parameters at baseline | |
| Hb in g/L | 145 (127-153) |
| Platelet count as × 103/μL | 275 (232-344) |
| Leukocyte count as × 103/μL | 6.7 (5.2-8.5) |
| Lymphocyte count as × 103/μL | 1.7 (1.2-2.7) |
| Serum creatinine in mg/L | 8 (6-9) |
| Blood urea nitrogen in mg/L | 144 (116-177) |
| C-reactive protein in mg/L | 4 (3-9) |
| Fecal calprotectin in pg/g | 278 (77.5-660) |
| Erythrocyte sedimentation rate in mm/hour | 8 (4-15) |
| Baseline CDC frequency | 14/101 (13.9) |
| Baseline CDI frequency | 2/101 (2.0) |
- Citation: Morado-Aramburo O, Ochoa-Hein E, Pérez-Gutiérrez MT, Sánchez-Cruz MN, Bobadilla-del-Valle M, Yamamoto-Furusho JK, Ponce-de-Leon A, Sifuentes-Osornio J. Association between Clostridioides difficile colonization and inflammatory bowel disease activity in outpatients with remission. World J Gastroenterol 2026; 32(35): 118677
- URL: https://www.wjgnet.com/1007-9327/full/v32/i35/118677.htm
- DOI: https://dx.doi.org/10.3748/wjg.118677